Skip to content
Search

Latest Stories

GZERO World Clips

Highlights from the GZERO World with Ian Bremmer weekly television show.

On Thursday, February 4, Johnson & Johnson requested emergency FDA approval for its single-shot vaccine. In the days since the company first released efficacy and safety data, many of the headlines focused on its lower efficacy rate compared to that of mRNA vaccines from Pfizer and Moderna. But that's the wrong takeaway, says surgeon, public health expert and former member of Biden-Harris Transition COVID-19 Advisory Board, Dr. Atul Gawande. "This is a highly effective vaccine. It stops people from getting sick. If some people have some sniffles and mild effects from the coronavirus, that's okay, this is going to stop the deadly disease. And that is the ultimate goal of the vaccine."

Gawande's conversation with Ian Bremmer is part of the latest episode of GZERO World, which starts airing on public television nationwide beginning this Friday, February 5th. Check local listings.

More from GZERO World Clips

About the Show

Every week on GZERO World with Ian Bremmer, Ian explains the key global stories of the moment, sits down for an in-depth conversation with the newsmakers and thought leaders shaping our world.

Watch GZERO World on US public television and on GZERO's YouTube channel. GZERO WORLD with Ian Bremmer is a local public television program presented by THIRTEEN PBS.

GZERO Series

​Israel, Hezbollah, and the battle for Lebanon’s future

GZERO World with Ian Bremmer

GZERO World with Ian Bremmer
Putin, Trump, and the power of YES

Puppet Regime

Puppet Regime
Mounting pressure between US and Iran with no end in sight

Quick Take

Quick Take
Why AI needs a global referee

ask ian

ask ian
How Hezbollah in Lebanon became Iran's most powerful proxy force

Ian Explains

Ian Explains
A frozen labor market in the US?

GZERO Reports

GZERO Reports
UK’s new prime minister faces an uphill battle

GZERO Europe

GZERO Europe
Democrats have a Platner problem – even after Platner

The Debrief

The Debrief